2 research outputs found
Exploring the Benzimidazole Ring as a Substitution for Indole in Cannabinoid Allosteric Modulators
Introduction and Objectives:
The traditional approach to target a particular receptor is to design compounds
that bind to the same site as the endogenous ligand, the so-called ‘‘orthosteric site.’’ However, recently the search
has shifted to ligands that can interact with a different region of the receptor protein, the ‘‘allosteric site,’’ since
this approach offers potential pharmacological and therapeutic advantages. The aim of our work was to explore
the benzimidazole heterocycle as a novel scaffold for cannabinoid allosterism.
Materials and Methods:
We synthesized a series of novel benzimidazole-2-carboxamides, analogues of
ORG27569, and performed their pharmacological characterization as CB
1
R allosteric modulators using compe-
titive [
3
H]-CP55940 and [
35
S]-GTP
c
S binding assays.
Results:
The benzimidazoles
3
and
4
produced significant negative allosteric modulation (NAM) of CP55940
agonism at the mouse CB
1
R, although are somewhat less potent than the CB
1
R allosteric cannabinoid ORG27569.
Conclusions:
Replacing the indole ring with a benzimidazole ring within the structure of ORG27569 abolished
the binding of the resultant ligands to CB
1
R, but the modulation on the agonist-induced GTP
c
S binding was
maintainedThe authors gratefully acknowledge research support
from Spanish Grant SAF2012-400075-C02-02 and
CAM S2010/BMD-2308. P.M. is recipient of a fellowship
JAE-Pre-2010-01119 from ‘‘Junta para la Ampliación de Estudios’’ that is co-financed by FSE.Peer Reviewe